Sun Pharma Faces Rs 1.11 Crore Tax Demand Over Disallowed Input Tax Credit

Sun Pharmaceutical Industries Ltd faces Rs 1.11 crore tax demand over disallowed input tax credit, as per a recent order from the Joint Commissioner, CGST and Central Excise.
29-04-2024

Sun Pharma - Specialty' Way Of Driving Growth Prospects: Motilal Oswal

Values Sun Pharma at 30 times 12 months forward earnings to arrive at a target price of Rs 1,870.
24-04-2024
Next Page
Close

Let's Open Free Demat Account